查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1754258

2025 年至 2033 年醫療外骨骼市場規模、佔有率、趨勢及預測（按組件、類型、肢體、移動性、最終用戶和地區）

Medical Exoskeleton Market Size, Share, Trends and Forecast by Component, Type, Extremity, Mobility, End User, and Region, 2025-2033
出版日期: | 出版商: IMARC | 英文 143 Pages | 商品交期: 2-3個工作天內

價格

2024年，全球醫療外骨骼市場規模達4.9515億美元。展望未來， IMARC Group預測，到2033年，該市場規模將達到55.2206億美元，2025-2033年期間的複合年成長率為29.19%。目前，北美佔據市場主導地位，2024年將佔據36.5%的顯著市場。投資和資金的增加推動了創新，使外骨骼更有效率、更方便。人工智慧(AI)和感測器技術的進步增強了即時運動適應能力，從而促進了更好的復健。監管部門的批准和保險覆蓋確保了醫療外骨骼的安全性和可負擔性，從而加速了市場佔有率的成長。

人口老化顯著推動了醫療外骨骼市場的發展，增加了對行動輔助的需求。老年人面臨更高的行動障礙風險，需要先進的日常活動支援解決方案。醫療外骨骼幫助老年人恢復行動能力，減少對照護者的依賴，並提高整體生活品質。關節炎和骨質疏鬆症等與年齡相關的疾病病例不斷增加，進一步刺激了對穿戴式外骨骼的需求。這些設備能夠增強穩定性並預防跌倒，解決老年人面臨的主要行動障礙。醫療保健提供者擴大推薦外骨骼輔助康復，以改善老年患者受傷後的康復效果。輕量化和符合人體工學的外骨骼設計的進步提高了舒適度，使其適合長期使用。人工智慧驅動的自適應運動支援系統可提供個人化輔助，滿足個人的行動需求。

不斷成長的研發投入極大地推動了美國醫療外骨骼市場的需求。政府資金和私部門的投資正在加速創新外骨骼技術的發展。領先的研究機構和大學與製造商合作，增強用於復健的機器人移動解決方案。例如，2025 年 2 月，Wandercraft 啟動了其個人外骨骼的關鍵臨床試驗，這是第一個供個人使用的自平衡設備。它專為行動不便人士設計，可恢復自然的步行動作。這項在詹姆斯彼得斯退伍軍人醫療中心進行的試驗將擴展到凱斯勒研究所，評估其對脊髓損傷的安全性和有效性。此外，外骨骼新創公司的風險投資正在促進競爭，從而帶來具有成本效益和可擴展性的產品。美國國防部在外骨骼研究方面投入巨資，支持為受傷退伍軍人和士兵提供應用。人工智慧驅動的運動控制和生物力學的進步提高了外骨骼的效率和自適應運動支援。醫療器材公司正專注於輕量化材料和節能設計，以提升使用者舒適度。 FDA 的批准和對穿戴式外骨骼的監管支持，確保了其更快的市場准入和更廣泛的應用。

醫療外骨骼市場趨勢：

穿戴式機器人技術的進步

穿戴式機器人技術的不斷進步顯著提升了醫療外骨骼的功能性、舒適性和適應性。科技進步使行動不便的使用者能夠更有效率地運動、更耐用地生活，並獲得個人化支援。輕量化材料、人工智慧驅動的運動控制和人體工學設計的創新提升了用戶體驗，使外骨骼在復健和日常使用中更加實用。現代外骨骼的設計旨在最大限度地減少身體壓力，支持肌肉參與，同時促進自然的運動模式。這些改進有助於改善復健效果，使患有神經系統疾病、脊髓損傷和因年齡相關行動障礙的患者能夠重獲獨立生活。先進的感測器技術和即時運動調節確保與使用者的身體運動無縫銜接。 2024年7月，Arc'teryx和Skip推出了MO/GO外骨骼健行褲，可減少40%的肌肉疲勞，支撐膝關節，並增強耐力。這項進展凸顯了穿戴式外骨骼的廣泛應用，展現了其在復健和行動輔助方面的潛力。

行動輔助需求不斷成長

醫療外骨骼能夠增強患者的獨立性、改善其活動能力並提升生活品質，使其成為康復中心和個人用戶的理想選擇。這些設備可幫助使用者恢復運動能力，使他們能夠更輕鬆地進行日常活動。配備人工智慧驅動的運動控制和基於感測器的自適應功能的先進機器人外骨骼進一步提升了用戶體驗。 2024年1月，哈佛大學和波士頓大學為帕金森氏症患者推出了一款軟體機器人外骨骼，可減少跌倒並消除「僵住」現象。這款配備線纜驅動執行器和運動感測器的穿戴式外骨骼代表了神經系統疾病輔助移動技術的重大進步。隨著關節炎、帕金森氏症和中風等與年齡相關的疾病日益增多，對增強運動能力和減少依賴性的輔助技術的需求也日益成長。

監管部門批准推動市場擴張

法規核准對於擴大醫療外骨骼市場、確保產品安全性、有效性和廣泛應用至關重要。 FDA、CE 和加拿大衛生部等衛生部門的認證驗證了外骨骼的性能，增強了消費者和醫療保健提供者的信心。隨著越來越多的設備獲得監管部門的批准，企業可以推出先進的復健和行動支援解決方案，從而促進市場成長。核准流程涉及嚴格的測試，以確保外骨骼符合安全標準並為行動不便的使用者提供有效的幫助。政府的措施和支持性政策進一步加快了法規核准，鼓勵了醫療應用穿戴式機器人的創新。 2024 年 9 月，Human in Motion Robotics 獲得批准在加拿大銷售 XoMotion，這是世界上最先進的自平衡、免持醫療外骨骼。這款突破性的設備旨在幫助脊髓損傷、中風和神經系統疾病患者，代表了醫療外骨骼技術的重大飛躍。

目錄

第1章：前言

第2章：範圍與方法

  • 研究目標
  • 利害關係人
  • 資料來源
    • 主要來源
    • 次要來源
  • 市場評估
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第3章：執行摘要

第4章：簡介

  • 概述
  • 主要行業趨勢

第5章：全球醫療外骨骼市場

  • 市場概覽
  • 市場表現
  • COVID-19的影響
  • 市場預測

第6章：市場細分：按組成部分

  • 硬體
  • 軟體

第7章：市場區隔：依類型

  • 動力外骨骼
  • 被動外骨骼

第8章：市場分化：極端狀況

  • 下肢醫療外骨骼
  • 上肢醫療外骨骼
  • 全身

第9章：市場區隔：依移動性

  • 移動外骨骼
  • 固定式外骨骼

第10章：市場區隔：依最終用戶

  • 復健中心
  • 物理治療中心
  • 其他

第 11 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場區隔：依國家

第 12 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 13 章：價值鏈分析

第 14 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 15 章：價格分析

第 16 章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • B-Temia Inc.
    • Cyberdyne Inc.
    • Ekso Bionics Holdings Inc.
    • ExoAtlet Global SA
    • GOGOA Mobility Robots
    • Hocoma AG (DIH International Limited)
    • Myomo Inc.
    • ReWalk Robotics Ltd
    • Rex Bionics Ltd.
    • suitX Inc. (Ottobock SE & Co. KGaA)
    • Wandercraft
    • Wearable Robotics Srl
Product Code: SR112025A6535

The global medical exoskeleton market size was valued at USD 495.15 Million in 2024. Looking forward, IMARC Group estimates the market to reach USD 5,522.06 Million by 2033, exhibiting a CAGR of 29.19% during 2025-2033. North America currently dominates the market, holding a significant market share of 36.5% in 2024. Increased investments and funding drive innovation, making exoskeletons more efficient and accessible. Advancements in artificial intelligence (AI) and sensor technology enhance real-time movement adaptation for better rehabilitation. Regulatory approvals and insurance coverage accelerate medical exoskeleton market share by ensuring safety and affordability.

The aging population is significantly driving the medical exoskeleton market by increasing demand for mobility assistance. Elderly individuals face higher risks of mobility impairments, requiring advanced solutions for daily movement support. Medical exoskeletons help seniors regain mobility, reducing dependence on caregivers and improving overall quality of life. Rising cases of age-related conditions like arthritis and osteoporosis further catalyzes the demand for wearable exoskeletons. These devices provide enhanced stability and fall prevention, addressing key mobility challenges among older adults. Healthcare providers increasingly recommend exoskeleton-assisted rehabilitation, improving recovery outcomes for elderly patients after injuries. Advancements in lightweight and ergonomic exoskeleton designs enhance comfort, making them suitable for extended use. AI-driven adaptive movement support systems allow personalized assistance, catering to individual mobility needs.

Growing investment in research and development (R&D) is significantly driving the United States medical exoskeleton market demand. Government funding and private sector investments are accelerating the development of innovative exoskeleton technologies. Leading research institutions and universities collaborate with manufacturers, enhancing robotic mobility solutions for rehabilitation. For instance, in February 2025, Wandercraft initiated a pivotal clinical trial for its Personal Exoskeleton, the first self-balancing device for personal use. Designed for individuals with severe mobility impairments, it restores natural walking motions. The trial, underway at the James J. Peters VA Medical Center, will expand to Kessler Institute, evaluating its safety and effectiveness for spinal cord injuries. Moreover, venture capital funding for exoskeleton startups is fostering competition, leading to cost-effective and scalable products. The US Department of Defense invests heavily in exoskeleton research, supporting applications for injured veterans and soldiers. Advancements in AI-driven motion control and biomechanics improve exoskeleton efficiency and adaptive movement support. Medical device companies are focusing on lightweight materials and energy-efficient designs, enhancing user comfort. FDA approvals and regulatory support for wearable exoskeletons ensure faster market entry and increased adoption.

Medical Exoskeleton Market Trends:

Advancements in Wearable Robotics Technology

Continuous advancements in wearable robotics are significantly improving the functionality, comfort, and adaptability of medical exoskeletons. Technological progress is enabling more efficient movement, increased durability, and personalized support for users with mobility impairments. Innovations in lightweight materials, AI-driven motion control, and ergonomic designs enhance user experience, making exoskeletons more practical for rehabilitation and daily use. Engineered to minimize physical strain, modern exoskeletons support muscle engagement while facilitating natural movement patterns. These enhancements contribute to improved rehabilitation outcomes, allowing patients with neurological disorders, spinal cord injuries, and age-related mobility challenges to regain independence. Advanced sensor technology and real-time motion adjustment ensure seamless integration with the user's body movements. In July 2024, Arc'teryx and Skip introduced MO/GO exoskeleton hiking pants, reducing muscle fatigue by 40%, supporting knee joints, and enhancing endurance. This development highlights the broader application of wearable exoskeletons, showcasing their potential for rehabilitation and mobility assistance.

Increasing Demand for Mobility Assistance

Medical exoskeletons provide greater independence, improved mobility, and enhanced quality of life, making them an attractive choice for both rehabilitation centers and personal use. These devices assist users in regaining movement, enabling them to perform daily activities with greater ease. Advanced robotic exoskeletons equipped with AI-driven motion control and sensor-based adaptability further improve user experience. In January 2024, Harvard and Boston University introduced a soft robotic exoskeleton for Parkinson's patients, reducing falls and eliminating "freezing" episodes. This wearable exoskeleton with cable-driven actuators and movement sensors represents a major advancement in assistive mobility technology for neurological disorders. As age-related disorders such as arthritis, Parkinson's disease, and stroke become more common, there is a growing need for assistive technologies that enhance movement and reduce dependency.

Regulatory Approvals Driving Market Expansion

Regulatory approvals are crucial for expanding the medical exoskeleton market, ensuring product safety, efficacy, and widespread adoption. Certification from health authorities such as the FDA, CE, and Health Canada validates the performance of exoskeletons, increasing consumer and healthcare provider confidence. As more devices receive regulatory clearance, companies can introduce advanced solutions for rehabilitation and mobility support, strengthening market growth. Approval processes involve rigorous testing, ensuring exoskeletons meet safety standards and deliver effective assistance for users with mobility impairments. Government initiatives and supportive policies further accelerate regulatory approvals, encouraging innovation in wearable robotics for healthcare applications. In September 2024, Human in Motion Robotics secured approval to market XoMotion, the world's most advanced self-balancing, hands-free medical exoskeleton, in Canada. This breakthrough device is designed to assist patients with spinal cord injuries, stroke, and neurological conditions, representing a significant leap in medical exoskeleton technology.

Medical Exoskeleton Industry Segmentation:

Analysis by Component:

  • Hardware
  • Software

Hardware leads the market with 84.0% of market share in 2024. Critical components like sensors, actuators, and power systems contribute significantly to exoskeleton performance and cost. Advanced motion sensors and AI-driven controllers enhance mobility assistance, ensuring precise movement adaptation for users. Lightweight yet durable materials like carbon fiber and titanium improve comfort and long-term usability. High-performance actuators and motors provide necessary force, enabling exoskeletons to assist movement efficiently. Battery advancements play a crucial role, as improved power efficiency extends operational time for continuous mobility support. The high cost of developing and manufacturing hardware makes it the largest revenue-generating segment in the market. Manufacturers focus on hardware improvements, integrating miniaturized components to enhance wearability and comfort. Hardware components undergo rigorous testing and regulatory approvals, further increasing development costs and market share. Innovations in biomechanical engineering ensure seamless interaction between exoskeleton hardware and the human body. Increasing demand for robotic rehabilitation solutions drives continuous improvements in hardware technologies.

Analysis by Type:

  • Powered Exoskeletons
  • Passive Exoskeletons

Powered exoskeletons lead the market with 87.8% of market share in 2024. These systems use electric motors, hydraulics, or pneumatics, providing active support for users with mobility impairments. AI-driven control systems enable real-time movement adjustments, ensuring adaptive support based on user needs. Rehabilitation centers and hospitals prefer powered exoskeletons, as they offer enhanced gait training for patients. Advanced battery technologies improve operational efficiency, reducing downtime and increasing user independence. The increasing prevalence of neurological disorders and spinal cord injuries drives demand for powered exoskeletons. Their ability to generate mechanical force makes them ideal for individuals with severe mobility challenges. Ongoing advancements in robotic exoskeletons continue to improve weight distribution and comfort for extended wear. Rising government support and insurance reimbursements make powered exoskeletons more accessible for medical and personal use. Leading manufacturers focus on developing lightweight, high-performance exoskeletons, expanding their application in healthcare. Wearable robotics innovations enhance energy efficiency, making powered exoskeletons more practical for daily use. The growing demand for automated rehabilitation solutions further cements powered exoskeletons as the leading market segment.

Analysis by Extremity:

  • Lower Extremity Medical Exoskeletons
  • Upper Extremity Medical Exoskeletons
  • Full Body

Lower extremity medical exoskeletons dominate the market with 52.6% of market share in 2024. Patients with spinal cord injuries, stroke, and neuromuscular disorders benefit significantly from lower limb exoskeletons. These devices enhance gait training, allowing individuals to regain walking ability through rehabilitation therapy. Hospitals and rehabilitation centers widely adopt lower extremity exoskeletons, increasing their market demand. Improved biomechanical engineering ensures seamless movement synchronization, enhancing user comfort and efficiency. The rising geriatric population further increases demand for lower limb support solutions. These exoskeletons reduce the risk of falls, improving mobility in elderly and disabled individuals. Technological advancements in motorized knee and hip support enhance functionality and ease of use. AI-driven motion assistance provides personalized support, ensuring adaptive rehabilitation therapy for users. The high cost of lower extremity exoskeletons reflects the complexity of their mechanics and design. Healthcare professionals prioritize lower limb exoskeletons, as walking rehabilitation is a primary focus in physical therapy. Research in lightweight and energy-efficient materials continues to improve lower extremity exoskeleton performance.

Analysis by Mobility:

  • Mobile Exoskeletons
  • Stationary Exoskeletons

Mobile exoskeletons are gaining traction due to their ability to provide real-time mobility assistance for users. These devices allow individuals with spinal cord injuries, stroke, or neurological disorders to regain independent movement. Advancements in AI-driven motion control and lightweight materials enhance comfort and adaptability. Rehabilitation centers and home users increasingly adopt mobile exoskeletons for daily mobility support. Battery efficiency and wireless connectivity improvements further enhance their practicality.

Stationary exoskeletons are widely used in rehabilitation centers for controlled therapy and muscle reactivation. These devices provide targeted assistance for patients recovering from spinal cord injuries, stroke, or musculoskeletal disorders. Healthcare professionals prefer stationary exoskeletons for supervised gait training and muscle strengthening programs. Advanced robotics and sensor technologies enable precise movement patterns, improving rehabilitation outcomes. Government initiatives and insurance coverage for robotic therapy support market growth. Hospitals and therapy centers continue investing in stationary exoskeletons for structured rehabilitation programs.

Analysis by End User:

  • Rehabilitation Centers
  • Physiotherapy Centers
  • Others

Rehabilitation centers lead the market with 50.7% of market share in 2024. These facilities integrate exoskeletons into therapy programs, helping patients regain mobility after injuries. Exoskeleton-assisted rehabilitation improves walking ability, making it a preferred solution for physical therapy. Rising cases of spinal cord injuries and stroke-related mobility issues drive demand for rehabilitation services. Medical professionals use exoskeletons for gait training, enhancing patient recovery outcomes. Hospitals and clinics partner with exoskeleton manufacturers, ensuring access to the latest rehabilitation technologies. Government healthcare initiatives support rehabilitation programs, increasing market growth for medical exoskeletons. Advanced AI-driven rehabilitation exoskeletons offer personalized therapy, improving patient progress tracking. Higher insurance reimbursements for exoskeleton-based therapy encourage rehabilitation centers to invest in this technology. Continuous research and development (R&D) in robotic rehabilitation solutions ensures exoskeletons remain an essential part of physiotherapy. The increasing focus on patient-centered care drives the adoption of medical exoskeletons in therapy.

Regional Analysis:

  • North America
    • United States
    • Canada
  • Europe
    • Germany
    • France
    • United Kingdom
    • Italy
    • Spain
    • Russia
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Australia
    • Indonesia
    • Others
  • Latin America
    • Brazil
    • Mexico
    • Others
  • Middle East and Africa

In 2024, North America accounted for the largest market share of 36.5%. The United States and Canada invest heavily in medical robotics, accelerating exoskeleton research and development (R&D). Government initiatives and funding for assistive technologies fuels the market growth in the region. Leading medical exoskeleton manufacturers are headquartered in North America, strengthening the market landscape. High prevalence of spinal cord injuries and neurological disorders increases demand for mobility assistance solutions. Strong collaborations between research institutions and healthcare providers drive exoskeleton innovation and adoption. Expanding insurance coverage for exoskeleton-assisted rehabilitation enhances patient accessibility in the region. Military and defense research on wearable robotics further contributes to market expansion. Artificial intelligence (AI) and Internet of Things (IoT)-driven advancements in medical robotics position North America as a global leader in exoskeleton technology. Rising geriatric population and mobility impairments increase the demand for advanced rehabilitation solutions. Widespread presence of rehabilitation centers and hospitals accelerates medical exoskeleton integration into therapy. Venture capital investments in healthcare robotics startups fuel market expansion. Continuous technological improvements in wearable robotics strengthen North America's dominance.

Key Regional Takeaways:

United States Medical Exoskeleton Market Analysis

The United States hold 91.10% of the market share in North America. The rising incidence of spinal cord injuries and work-related musculoskeletal disorders is significantly accelerating the growth of the market. According to the National Spinal Cord Injury Statistical Center (NSCISC), approximately 17,730 new spinal cord injuries are diagnosed annually in the US, with nearly 291,000 individuals currently living with SCIs. These injuries often lead to long-term mobility impairments, increasing the need for effective rehabilitation solutions such as medical exoskeletons. Workplace injuries further contribute to market expansion, with musculoskeletal disorders being a major concern across industries. The US Bureau of Labor Statistics reported 502,380 cases of occupational musculoskeletal disorders in 2022, highlighting the growing demand for assistive mobility technologies to aid recovery. As more workers require advanced rehabilitation solutions, the adoption of medical exoskeletons continues to rise. Market growth is further supported by technological advancements in robotic exoskeletons, favorable insurance policies, and increased healthcare funding. Expanding research efforts, AI-driven innovations, and greater accessibility to rehabilitation technologies are expected to drive significant market expansion. With ongoing developments in wearable robotics and increasing support for mobility assistance, the US medical exoskeleton market outlook is set for substantial growth in the coming years.

Asia Pacific Medical Exoskeleton Market Analysis

The Asia Pacific market is expanding rapidly, driven by technological advancements and growing collaborations in assistive mobility solutions. In June 2022, CYBERDYNE Inc. partnered with Malaysia's Social Security Organization (SOCSO) to expand Cybernics Treatment using its Hybrid Assistive Limb (HAL) exoskeleton. This initiative has increased access to robotic rehabilitation for SOCSO-insured patients, accelerating the adoption of medical exoskeletons across Southeast Asia. India's health tech sector is also advancing in robotic exoskeleton development, contributing to regional market growth. In 2020, GenElek Technologies, a New Delhi-based startup, introduced an advanced robotic exoskeleton designed to assist individuals with mobility impairments. The rising prevalence of spinal cord injuries, neurological disorders, and workplace-related musculoskeletal conditions is further driving demand. Increasing government support, healthcare investments, and the expansion of rehabilitation facilities integrating exoskeleton technology are strengthening the market growth. Innovations in AI-driven mobility solutions and improvements in affordability are making exoskeletons more accessible across the region.

Europe Medical Exoskeleton Market Analysis

The rising prevalence of neurological diseases is a key driver of the Europe market, fueling demand for assistive mobility solutions. According to the European Academy of Neurology (EAN), one in three people worldwide experience a neurological disorder in their lifetime. Conditions such as stroke, multiple sclerosis, Parkinson's disease, and spinal cord injuries significantly impact mobility, increasing the need for advanced rehabilitation technologies in Europe. Medical exoskeletons enhance mobility and independence, playing a vital role in neurological rehabilitation and long-term care. European governments and healthcare providers are heavily investing in robotic-assisted therapy, recognizing its benefits for patient recovery. Advancements in AI-powered exoskeletons and wearable robotics are further driving innovation and adoption across the region. Supportive reimbursement policies and growing integration of exoskeletons in hospitals and rehabilitation centers are strengthening market expansion. As neurological disorders continue to rise, the demand for cutting-edge medical exoskeletons is expected to grow. With continuous technological progress and increased healthcare funding, the Europe medical exoskeleton market is poised for substantial long-term growth.

Latin America Medical Exoskeleton Market Analysis

The rapidly aging population in Latin America is a major driver inducing growth in the medical exoskeleton market. Industry reports show that Brazil's population aged 65 and older grew by 57%, increasing from 14.1 million in 2010 to 22.2 million in 2022. This demographic now comprises 11% of the total population, with another 10 million individuals aged 60-65 requiring mobility assistance. Age-related conditions such as stroke, arthritis, and neurodegenerative disorders are further driving demand for assistive robotic exoskeletons. Governments and healthcare providers in Brazil, Mexico, and Argentina are investing in advanced rehabilitation technologies to enhance mobility solutions for elderly individuals. Expanding healthcare infrastructure and rising public awareness are contributing to greater adoption of wearable exoskeletons. AI-powered robotics and smart rehabilitation systems are further revolutionizing elderly care, making exoskeletons more effective and accessible.

Middle East and Africa Medical Exoskeleton Market Analysis

The Middle East and Africa region market is expanding due to rising investments in robotic technologies and healthcare applications. The growing adoption of exoskeletons in rehabilitation centers and hospitals is propelling market growth across the region. In February 2021, Paramount Group and Sarcos Robotics signed an agreement to introduce advanced robotic systems for defense and industrial use. This initiative has paved the way for integrating exoskeleton technology into medical and assistive mobility solutions. The increasing prevalence of spinal cord injuries, stroke, and musculoskeletal disorders has intensified the need for robotic rehabilitation devices. Governments in the region are investing in healthcare infrastructure and promoting awareness of assistive technologies, further accelerating market expansion. International collaborations with leading exoskeleton manufacturers are enhancing accessibility to cutting-edge wearable robotics. As technological advancements continue, medical exoskeleton adoption is expected to rise across the Middle East and Africa.

Competitive Landscape:

Major companies are spending immensely in research and development (R&D) to improve exoskeleton efficiency, comfort, and functionality. Strategic partnerships between medical device firms and technology companies accelerate advancements in AI-driven mobility solutions. Moreover, AI-powered exoskeletons are transforming rehabilitation by enhancing mobility for individuals with spinal cord injuries and neurological conditions. To expand the horizon of AI integration, Ekso Bionics hosted a webinar in November 2024. Katherine Strausser, Principal Controls Engineer, joined the AI for Good webinar, "AI-powered Exo skeletons Revolutionizing Rehabilitation and Mobility". The session discusses advancements in exoskeleton technology and its impact on medical rehabilitation. Interested participants can register online. Additionally, major manufacturers are focusing on lightweight materials and ergonomic designs, enhancing user experience and long-term wearability. Continuous product innovation by key players ensures medical exoskeletons meet evolving rehabilitation and mobility assistance needs. Collaborations with healthcare providers and rehabilitation centers expand exoskeleton accessibility for patients with mobility impairments. Key players prioritize regulatory compliance and safety standards, ensuring approval from government agencies like FDA and CE. Expanding production capabilities and distribution networks allow companies to penetrate emerging markets and increase adoption. Investments in AI and sensor technology enhance real-time movement adaptation, providing personalized support for users.

The report provides a comprehensive analysis of the competitive landscape in the medical exoskeleton market with detailed profiles of all major companies, including:

  • B-Temia Inc.
  • Cyberdyne Inc.
  • Ekso Bionics Holdings Inc.
  • ExoAtlet Global S.A.
  • GOGOA Mobility Robots
  • Hocoma AG (DIH International Limited)
  • Myomo Inc.
  • ReWalk Robotics Ltd
  • Rex Bionics Ltd.
  • suitX Inc. (Ottobock SE & Co. KGaA)
  • Wandercraft
  • Wearable Robotics Srl

Key Questions Answered in This Report

  • 1.How big is the medical exoskeleton market?
  • 2.What is the future outlook of medical exoskeleton market?
  • 3.What are the key factors driving the medical exoskeleton market?
  • 4.Which region accounts for the largest medical exoskeleton market share?
  • 5.Which are the leading companies in the global medical exoskeleton market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Medical Exoskeleton Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Hardware
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 Software
    • 6.2.1 Market Trends
    • 6.2.2 Market Forecast

7 Market Breakup by Type

  • 7.1 Powered Exoskeletons
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Passive Exoskeletons
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast

8 Market Breakup by Extremity

  • 8.1 Lower Extremity Medical Exoskeletons
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Upper Extremity Medical Exoskeletons
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Full Body
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Mobility

  • 9.1 Mobile Exoskeletons
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Stationary Exoskeletons
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast

10 Market Breakup by End User

  • 10.1 Rehabilitation Centers
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Physiotherapy Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia-Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Analysis

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 B-Temia Inc.
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
    • 16.3.2 Cyberdyne Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
    • 16.3.3 Ekso Bionics Holdings Inc.
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 ExoAtlet Global S.A.
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 GOGOA Mobility Robots
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 Hocoma AG (DIH International Limited)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
    • 16.3.7 Myomo Inc.
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
      • 16.3.7.3 Financials
    • 16.3.8 ReWalk Robotics Ltd
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
    • 16.3.9 Rex Bionics Ltd.
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
    • 16.3.10 suitX Inc. (Ottobock SE & Co. KGaA)
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
    • 16.3.11 Wandercraft
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
    • 16.3.12 Wearable Robotics Srl
      • 16.3.12.1 Company Overview
      • 16.3.12.2 Product Portfolio

List of Figures

  • Figure 1: Global: Medical Exoskeleton Market: Major Drivers and Challenges
  • Figure 2: Global: Medical Exoskeleton Market: Sales Value (in Million USD), 2019-2024
  • Figure 3: Global: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 4: Global: Medical Exoskeleton Market: Breakup by Component (in %), 2024
  • Figure 5: Global: Medical Exoskeleton Market: Breakup by Type (in %), 2024
  • Figure 6: Global: Medical Exoskeleton Market: Breakup by Extremity (in %), 2024
  • Figure 7: Global: Medical Exoskeleton Market: Breakup by Mobility (in %), 2024
  • Figure 8: Global: Medical Exoskeleton Market: Breakup by End User (in %), 2024
  • Figure 9: Global: Medical Exoskeleton Market: Breakup by Region (in %), 2024
  • Figure 10: Global: Medical Exoskeleton (Hardware) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 11: Global: Medical Exoskeleton (Hardware) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 12: Global: Medical Exoskeleton (Software) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 13: Global: Medical Exoskeleton (Software) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 14: Global: Medical Exoskeleton (Powered Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 15: Global: Medical Exoskeleton (Powered Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 16: Global: Medical Exoskeleton (Passive Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 17: Global: Medical Exoskeleton (Passive Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 18: Global: Medical Exoskeleton (Lower Extremity Medical Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 19: Global: Medical Exoskeleton (Lower Extremity Medical Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 20: Global: Medical Exoskeleton (Upper Extremity Medical Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 21: Global: Medical Exoskeleton (Upper Extremity Medical Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 22: Global: Medical Exoskeleton (Full Body) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 23: Global: Medical Exoskeleton (Full Body) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 24: Global: Medical Exoskeleton (Mobile Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 25: Global: Medical Exoskeleton (Mobile Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 26: Global: Medical Exoskeleton (Stationary Exoskeletons) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 27: Global: Medical Exoskeleton (Stationary Exoskeletons) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 28: Global: Medical Exoskeleton (Rehabilitation Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 29: Global: Medical Exoskeleton (Rehabilitation Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 30: Global: Medical Exoskeleton (Physiotherapy Centers) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 31: Global: Medical Exoskeleton (Physiotherapy Centers) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 32: Global: Medical Exoskeleton (Other End Users) Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 33: Global: Medical Exoskeleton (Other End Users) Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 34: North America: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 35: North America: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 36: United States: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 37: United States: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 38: Canada: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 39: Canada: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 40: Asia-Pacific: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 41: Asia-Pacific: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 42: China: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 43: China: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 44: Japan: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 45: Japan: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 46: India: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 47: India: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 48: South Korea: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 49: South Korea: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 50: Australia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 51: Australia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 52: Indonesia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 53: Indonesia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 54: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 55: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 56: Europe: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 57: Europe: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 58: Germany: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 59: Germany: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 60: France: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 61: France: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 62: United Kingdom: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 63: United Kingdom: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 64: Italy: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 65: Italy: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 66: Spain: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 67: Spain: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 68: Russia: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 69: Russia: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 70: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 71: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 72: Latin America: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 73: Latin America: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 74: Brazil: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 75: Brazil: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 76: Mexico: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 77: Mexico: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 78: Others: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 79: Others: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 80: Middle East and Africa: Medical Exoskeleton Market: Sales Value (in Million USD), 2019 & 2024
  • Figure 81: Middle East and Africa: Medical Exoskeleton Market: Breakup by Country (in %), 2024
  • Figure 82: Middle East and Africa: Medical Exoskeleton Market Forecast: Sales Value (in Million USD), 2025-2033
  • Figure 83: Global: Medical Exoskeleton Industry: SWOT Analysis
  • Figure 84: Global: Medical Exoskeleton Industry: Value Chain Analysis
  • Figure 85: Global: Medical Exoskeleton Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Medical Exoskeleton Market: Key Industry Highlights, 2024 and 2033
  • Table 2: Global: Medical Exoskeleton Market Forecast: Breakup by Component (in Million USD), 2025-2033
  • Table 3: Global: Medical Exoskeleton Market Forecast: Breakup by Type (in Million USD), 2025-2033
  • Table 4: Global: Medical Exoskeleton Market Forecast: Breakup by Extremity (in Million USD), 2025-2033
  • Table 5: Global: Medical Exoskeleton Market Forecast: Breakup by Mobility (in Million USD), 2025-2033
  • Table 6: Global: Medical Exoskeleton Market Forecast: Breakup by End User (in Million USD), 2025-2033
  • Table 7: Global: Medical Exoskeleton Market Forecast: Breakup by Region (in Million USD), 2025-2033
  • Table 8: Global: Medical Exoskeleton Market: Competitive Structure
  • Table 9: Global: Medical Exoskeleton Market: Key Players